| Detected | Trial | Change |
|---|---|---|
| 2026-06-06 | NCT03531255 Pegcetacoplan Long Term Safety and Efficacy Extension Study |
Trial completed |
| 2026-06-06 | NCT03531255 Pegcetacoplan Long Term Safety and Efficacy Extension Study |
date change Primary completion moved earlier: 2025-11-29 -> 2025-09-04 |
| 2026-06-06 | NCT03531255 Pegcetacoplan Long Term Safety and Efficacy Extension Study |
date change Completion moved earlier: 2026-07 -> 2026-05-19 |
| 2026-06-04 | NCT03531255 Pegcetacoplan Long Term Safety and Efficacy Extension Study |
Enrollment reduced: 160 -> 137 participants |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07020832 | A Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High… | Delayed Graft Function | Recruiting |
| NCT05809531 | An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term… | C3G | Active, Not Recruiting |
| Phase 2 | |||
| NCT04919629 | APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab… | Fallopian Tube Carcinosarcoma | Recruiting |
| NCT06722157 | A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related… | Macular Degeneration, Age-related | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT07160179 | Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body… | Geographic Atrophy | Recruiting |
| NCT07214298 | Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic… | Metastatic Pancreatic Ductal Adenocarcinoma | Recruiting |
| Phase 1 | |||
| NCT07495722 | Safely Quenching Complement in Stroke Survivors | Acute Ischemic Stroke | Not Yet Recruiting |
| Not specified | |||
| NCT06161584 | A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate… | Geographic Atrophy | Active, Not Recruiting |